Therapeutic Plasma Exchange for Treatment-Resistant Tumefactive Demyelinating Lesion: A Case Report.
| Autor: | Vilayet S; Division of Nephrology, Medical University of South Carolina, Charleston, USA., Hayes E; Division of Nephrology, Medical University of South Carolina, Charleston, USA., Barakat M; Division of Nephrology, Medical University of South Carolina, Charleston, USA., Budisavljevic M; Division of Nephrology, Medical University of South Carolina, Charleston, USA., Achanti A; Division of Nephrology, Medical University of South Carolina, Charleston, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 Feb 07; Vol. 16 (2), pp. e53786. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.53786 |
| Abstrakt: | Tumefactive demyelinating lesions (TDLs) can present as an isolated clinical incidence or could represent the initial presentation of multiple sclerosis. Radiological TDLs are characterized by large tumors like >2 cm space-occupying lesions with mass effect and perilesional edema. Diagnosis is based on MRI imaging and extensive work to exclude other causes and a biopsy of the lesion is often required. First-line treatments include pulsed methylprednisolone. We present a case of a refractory TDL treated successfully with therapeutic plasma exchange. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Vilayet et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|